Company Analysis

60 Degrees Pharmaceuticals, Inc. (SXTP)

Nasdaq: SXTP · Pharmaceutical Preparations · Washington, DC · filing with the SEC since 2022
Grade4.6
◀ Past 4.1● Present 3.3▶ Future 6.1
1 est.

Who runs 60 Degrees Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Dow Geoffrey S
President and CEO. First filing Jul 2023, latest Jun 15, 2026, 6 filings in all.
Officers reporting now
2
of 3 people with a filing in the last fifteen months
Directors reporting now
1
9 people on the record since 2023
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Dow Geoffrey SPresident and CEOJul 2023Jun 15, 2026none
Landon KristenChief Operating OfficerJan 2025Aug 14, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Francois EricdirectorMay 2026May 19, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Knight Therapeutics Inc10% ownerJul 2023Jul 29, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SXTP · research, not advice